Navigation Links
Spherix Announces First Quarter Financial Results
Date:5/13/2011

BETHESDA, Md., May 13, 2011 /PRNewswire/ -- Spherix Incorporated (NASDAQ: SPEXD) -- an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies -- today reported financial results for the three months ended March 31, 2011.

Recent and Upcoming Highlights

  • Pharmaceutical Development
  • Began a multi-unit research contract to investigate the role of D-tagatose in lowering triglycerides
  • Began preclinical animal testing of SPX10624258 in combination with D-tagatose
  • Seeking a strategic relationship with a pharmaceutical company for the continued development of D-tagatose as a treatment for Type 2 diabetes
  • Health Sciences Consulting
  • Recent and upcoming trade and professional shows:
  • April 9, 2011: Dr. Claire Kruger, Spherix CEO, spoke at the American Dietetic Association's Nutrition News Forecast 2011 in Chicago
  • May 16, 2011: Spherix Consulting's Principal Advisor, Dr. A. Wallace Hayes, will be presenting at the American College of Toxicology's Toxicology for Industrial and Regulatory Scientists Program, to be held in Falls Church, Va.; his presentation, "Basic Principles of Toxicology," was co-authored by Dr. Kruger
  • Corporate
  • Raised $2.77 million in a registered direct offering of common stock and warrants
  • On May 6, 2011, effected a one for ten reverse stock split of the Company's common stock

  • Financial Results for the Three Months Ended March 31, 2011The net loss for the first quarter of 2011 was $0.2 million or $0.10 per share, compared with a net loss for the first quarter of 2010 of $2.1 million or $1.25 per share.  The narrowing of the net loss was attributed mainly to lower research and development expenses, and gain on settlement of obligations of $0.8 mil
    '/>"/>

    SOURCE Spherix Incorporated
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related biology technology :

    1. Spherix Announces Reverse Stock Split Effective May 6, 2011
    2. Spherix to Effect Reverse Stock Split
    3. Spherix Announces 2010 Financial Results
    4. Spherix to Present at the BIO-Windhover/Pharmaceutical Strategic Outlook 2011 Conference
    5. Spherix to Present at the 13th Annual BIO CEO & Investor Conference
    6. Spherix Announces Closing of Registered Direct Offering of $2.77 Million in Common Stock and Warrants
    7. Spherix to Present at Two Upcoming Prominent Finance Conferences
    8. Spherix Phase 2 Trial with D-tagatose Determines Minimum Dose for HbA1c and Triglycerides
    9. Spherix Signs Research Contract With a Leading Global Contract Research Organization to Investigate Role of D-tagatose in Lowering Triglycerides
    10. Spherix to Hold Business Update Conference Call December 9, 2010 at 4:30 p.m. Eastern Time
    11. Spherix Announces Closing of Institutional Investors Purchase of $5.25 Million of Convertible Preferred Stock and Warrants
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/26/2015)... (PRWEB) February 26, 2015 The Movement ... demonstration to support life extension technologies and awareness. The ... Universal Coordinated Time, on March 21st 2015, in a ... , Eric Schulke, Founder of MILE, says, “Our ... with urgency. The Movement for Indefinite Life Extension is ...
    (Date:2/26/2015)... , Feb. 26, 2015  NuGene International, ... aesthetic products for skin and hair rejuvenation, has ... as agency of record for investor relations and ... improve our distribution, sales and diversification strategies – ... current and prospective shareholders," stated Ali Kharazmi CEO ...
    (Date:2/26/2015)... BioEnterprise today announced that Northeast ... $2 billion in growth funding during the past 13 ... sources, state – including the Ohio Third Frontier - ... has been raised in the past five years. ... the BioEnterprise Midwest Healthcare Growth Capital  Report.   ...
    (Date:2/26/2015)... IL (PRWEB) February 26, 2015 Already ... its gauging line by expanding its Length Gauge offerings ... ACANTO gauges. , Specifically, HEIDENHAIN’s pencil probe-style ... improved force specification. Two new 1Vpp, 12mm stroke ... lower force applications. One is a variant with a ...
    Breaking Biology Technology:Indefinite Life Extension Activists Organize Online Demonstration 2Indefinite Life Extension Activists Organize Online Demonstration 3NuGene International, Inc. Selects Capital Market Relations for Strategic Investor Relations 2NuGene International, Inc. Selects Capital Market Relations for Strategic Investor Relations 3More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 2More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 3More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 4Accuracy and Versatile Gauging Go Hand in Hand at HEIDENHAIN 2
    ... , FREDERICK, Md., Aug. 28 SABiosciences ... Magazine,s 2009 Top 30 Best Places to Work Industry Survey. Best ... most positive work environment, dedicated management, and innovative ways to motivate their ... award for biotech and pharmaceutical companies. , , ...
    ... Encorium Group, Inc. (Nasdaq: ENCO ), a full ... countries for many of the world,s leading pharmaceutical and biotechnology companies, ... from Nasdaq stating that since it had not, as of the ... ended June 30, 2009, it was then no longer in compliance ...
    ... BOSTON, Massachusetts and CHEADLE, England, ... Ltd., announce plans to,collaborate and configure their software ... vertebral fractures from images on bone,densitometers, to exchange ... , Optasia Medical Ltd. ...
    Cached Biology Technology:SABiosciences Ranked 17th on the Best Places to Work Industry Award for Biotech and Pharmaceutical Companies 2Encorium Announces Receipt of Letters from Nasdaq Regarding its Second Quarter 2009 Form 10-Q Filing 2Encorium Announces Receipt of Letters from Nasdaq Regarding its Second Quarter 2009 Form 10-Q Filing 3Cardea Technology Inc and Optasia Medical Ltd Announce Plans to Collaborate to Optimize Their Vertebral Fracture Assessment Tools 2
    (Date:2/5/2015)... Epic Sciences , a precision diagnostics company dedicated to improving ... , Ph.D., president and CEO, is scheduled to present at ... Valley, which is taking place at the Computer History Museum ... 26-28, 2015. Dr. Prahalad will give a ... Epic Sciences was a finalist in the PMWC,s Most Promising ...
    (Date:2/5/2015)... -- New Market Research Reports Title Global ... 2020 has Been Added to GrandViewReseach.com Report Database ... reach USD 5.10 billion by 2020, according to a ... help identify the site of tissue damage in case ... in medical imaging applications. They have been extensively used ...
    (Date:2/5/2015)... , Jan. 30, 2015  It is gratifying to ... and potential for genomic science as a means to ... prevention and treatment.  I was honored to participate in ... precision medicine program. Since the 1980s ... of genomics—from the first sequenced genome of a free ...
    Breaking Biology News(10 mins):Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2
    ... the heart of a novel agricultural technique to manage harmful ... be used to turn carbon dioxide emissions into soil-enriching limestone, ... in tropical areas, such as West Africa. Researchers ... dry, acidic soil and treated with a combination of natural ...
    ... short strands of RNA, known as microRNAs (miRNAs), have ... cancer and may provide information about prognosis. However, ... While the potential for using miRNAs in breast ... study published online today in The Journal of ...
    ... or cougars, are re-emerging in areas of the United ... in The Journal of Wildlife Management , raises ... alongside the returning predators. "The cougar population declined ... lack of prey, leaving the remaining population isolated to ...
    Cached Biology News:Bugs have key role in farming approach to storing CO2 emissions 2Researchers identify need to sample multiple tumor zones in breast cancer 2Cougars are re-populating their historical range, new study confirms 2
    ...
    ... Staining Kit, Protein, 1. Based on ... (1), the kit gives essentially colorless ... Staining Kit, Protein provides convenient, reproducible ... polyacrylamide gels in less than two ...
    Mouse monoclonal [IFR0104] to Salmonella enteriditis ( Abpromise for all tested applications)....
    Cyno macaque plasma and serum - various quantities available...
    Biology Products: